Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.33 |
| ▸ | MVD | P53602 | 1/20 | 0.33 |
| ▸ | EYA2 | O00167 | 1/20 | 0.33 |
| ▸ | APP | P05067 | 1/20 | 0.33 |
| ▸ | ACE | P12821 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.32 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | DRD1 | P21728 | 1/20 | 0.32 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.32 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.32 |
| ▸ | DRD3 | P35462 | 1/20 | 0.32 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL264900 | 0.79 | TDP1 (0.35) | TDP1EYA2APPACECYP3A4 | |
| SCHEMBL29840020 | 0.78 | ALOX15 (0.44) | TDP1MVDEYA2APPACE | |
| SCHEMBL28274977 | 0.77 | KMT2A (0.36) | CYP3A4LMNAKDM4ETSHR | |
| SCHEMBL25257486 | 0.77 | CHRNB2 (0.32) | TDP1MVDEYA2APPACE | |
| SCHEMBL25300840 | 0.77 | CHRNB2 (0.32) | TDP1MVDEYA2APPACE | |
| SCHEMBL16071866 | 0.76 | — | — | |
| SCHEMBL12121535 | 0.76 | — | — | |
| SCHEMBL28719684 | 0.76 | — | — | |
| SCHEMBL1535475 | 0.74 | LMNA (0.35) | TDP1MVDEYA2APPACE | |
| SCHEMBL17666080 | 0.74 | NPC1 (0.42) | TDP1EYA2APPACECYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12566161-B2 | Methods and consumer products for detecting a metabolite | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2026-03-03 | — | — | US | claimed |
| US-20230400438-A1 | METHODS AND CONSUMER PRODUCTS FOR DETECTING A METABOLITE | KIMBERLY-CLARK WORLDWIDE, INC. | 2023-12-14 | — | — | US | claimed |
| CN-116490772-A | Method and consumer product for detecting metabolites | 金伯利-克拉克环球有限公司 | 2023-07-25 | — | — | CN | claimed |
| CN-115754300-A | Plasma metabolism markers for predicting non-proliferative DR occurrence risk, application thereof and construction method of scoring model | 深圳市人民医院 | 2023-03-07 | — | — | CN | claimed |
| WO-2022190030-A1 | A TOPICAL FORMULATION FOR THE TREATMENT OF SKIN DISEASES | AVACA PHARMA PRIVATE LIMITED (IN) | 2022-09-15 | — | — | WO | claimed |
| WO-2022125056-A1 | METHODS AND CONSUMER PRODUCTS FOR DETECTING A METABOLITE | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2022-06-16 | — | — | WO | claimed |
| CN-106537145-B | Small molecule biochemical profiling of individual subjects for disease diagnosis and health assessment | 麦特博隆股份有限公司 | 2020-08-25 | — | — | CN | claimed |
| CN-108572251-B | Small molecule marker for early stage of cirrhosis and application thereof | 中国科学院昆明动物研究所 | 2020-01-17 | — | — | CN | claimed |
| US-12622876-B2 | Methods of suppressing delivery of exosomes to liver and spleen | LONZA SALES AG (CH) | 2026-05-12 | — | — | US | disclosed |
| US-12578322-B2 | Methods and consumer products for detecting a metabolite | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2026-03-17 | — | — | US | disclosed |
| US-12566161-B2 | Methods and consumer products for detecting a metabolite | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2026-03-03 | — | — | US | disclosed |
| US-12566161-B2 | Methods and consumer products for detecting a metabolite | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2026-03-03 | — | — | US | disclosed |
| US-12050228-B2 | Automated sample quality assessment | METABOLON, INC. (US) | 2024-07-30 | — | — | US | disclosed |
| US-20230417734-A1 | METHODS AND CONSUMER PRODUCTS FOR DETECTING A METABOLITE | KIMBERLY-CLARK WORLDWIDE, INC. | 2023-12-28 | — | — | US | disclosed |
| US-20150306212-A1 | SYNTHETIC MEMBRANE-RECEIVER COMPLEXES | FLAGSHIP VENTURES MANAGEMENT, INC. | 2015-10-29 | — | — | US | disclosed |
| WO-2015157407-A1 | SMALL MOLECULE BIOCHEMICAL PROFILING OF INDIVIDUAL SUBJECTS FOR DISEASE DIAGNOSIS AND HEALTH ASSESSMENT | METABOLON, INC. (US) | 2015-10-15 | — | — | WO | disclosed |
| WO-2015153102-A1 | METHODS AND COMPOSITIONS FOR IMMUNOMODULATION | RUBIUS THERAPEUTICS, INC. (US) | 2015-10-08 | — | — | WO | disclosed |
| US-20150182588-A1 | SYNTHETIC MEMBRANE-RECEIVER COMPLEXES | FLAGSHIP VENTURES MANAGEMENT, INC. | 2015-07-02 | — | — | US | disclosed |
| US-20150065366-A1 | Biomarkers for Bladder Cancer and Methods Using the Same | METABOLON, INC. | 2015-03-05 | — | — | US | disclosed |
| US-20110081675-A1 | Metabolic Biomarkers Of Drug-Induced Cardiotoxicity | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2011-04-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12622876-B2 | Methods of suppressing delivery of exosomes to liver and spleen | EXOSC10, EXOSC5, EXOSC4 | TDP1 4201/4885MVD 3704/4885EYA2 139/4885 |
| US-12566161-B2 | Methods and consumer products for detecting a metabolite | SLC6A6, SLC7A11, CTH | TDP1 3562/4885MVD 1050/4885EYA2 4305/4885 |
| US-12578322-B2 | Methods and consumer products for detecting a metabolite | SHBG, OXGR1, OGG1 | TDP1 3016/4885MVD 1088/4885EYA2 3303/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.